Church & Dwight Co., Inc. (NYSE: CHD) announced its financial results for the third quarter ended September 30, 2026, reporting net sales of $1,602 million, a 1.0% increase compared to the prior year. The company noted that this performance exceeded its outlook for the quarter and reflected the benefits of strategic portfolio actions taken in 2025. Organic sales grew by 5.1%, driven by volume increases of 4.6% and positive price and mix of 0.5%.

On a segment basis, Consumer Domestic net sales were $1,225 million, a 0.4% increase. Organic sales in this division grew 4.4%, driven by volume growth of 3.6% and favorable price and product mix of 0.8%. Key drivers included ARM & HAMMER Liquid Laundry Detergent, THERABREATH mouthwash and toothpaste, ARM & HAMMER cat litter, and WATERPIK water flossers. Consumer International net sales were $297 million, a 2.5% increase, with organic sales rising 7.8% due to higher volume of 9.1%, partially offset by lower price and product mix of 1.3%. The Specialty Products division reported net sales of $80 million, a 5.0% increase, with organic sales also growing 5.0%.

Gross margin for the quarter increased by 170 basis points to 46.8%. Reported earnings per share (EPS) were $0.89, compared to $0.75 in the prior year. Adjusted EPS was $0.92, representing a 13.6% increase versus last year and exceeding the company's outlook of $0.89. The company reported cash from operations of $380 million for the quarter.

Regarding the full year 2026 outlook, Church & Dwight raised its sales outlook to approximately 0.5% growth, versus the previous range of flat to 1%. The company also raised its full-year organic sales growth expectation to approximately 5%, the high end of the prior range of 4% to 5%. The company expects full-year reported EPS to increase approximately 20% and Adjusted EPS growth to be approximately 7%, tightening the prior range of 6% to 8%. The company projects full-year cash from operations to be approximately $1.175 billion.

Additionally, the company announced that its Board of Directors has approved a new share repurchase program authorizing the repurchase of up to $1 billion of common stock, with no expiration date. This replaces the company's existing share repurchase program.